| Bioactivity | Gypenoside XVII, a novel phytoestrogen belonging to the gypenosides, can activate estrogen receptors. |
| Invitro | The ability of Gypenoside XVII (GP-17) to prevent Ox-LDL-induced cytotoxicity is detected by cell viability assays. Gypenoside XVII does not demonstrate any cytotoxicity in HUVECs. Gypenoside XVII can protect HUVECs against Ox-LDL-induced apoptosis. Gypenoside XVII dose-dependently mitigates the toxic effect of Ox-LDL on HUVEC viability. The viability of HUVECs is significantly higher than that of other groups at 50 μg/mL Gypenoside XVII [1]. |
| Name | Gypenoside XVII |
| CAS | 80321-69-3 |
| Formula | C48H82O18 |
| Molar Mass | 947.15 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |